Becton Dickinson To Buy Pharmacy Automation Firm Parata Systems For $1.5 Billion

Coming into the fast-growing pharmacy automation house, Becton, Dickinson and Firm (BD) stated it can buy Parata Methods from Frazier Healthcare Companions for greater than $1.5 billion in money.

The medical product giant Monday said Parata might be part of the “medical phase” underneath BD’s “medicine administration options enterprise” and can broaden the corporate’s choices to supply “new progressive pharmacy automation options for hospitals, retail pharmacy, long-term care and residential settings,” an organization spokesman stated. The take care of the personal fairness agency Frazier is anticipated to shut transaction to shut by the top of the primary half of BD’s fiscal 12 months 2023, the companies said.

BD, which is best identified to shoppers for its diagnostic testing enterprise and medicine supply merchandise that embody syringes used to manage Covid-19 vaccines, might be coming into a $600 million U.S. pharmacy automation market that’s anticipated to develop 10% yearly to $1.5 billion over 10 years, the corporate stated.

BD stated Parata’s largest choices are with their “repackaging expertise and clever/digital workflow methods,” an organization spokesman stated. Such applied sciences permit affected person particular prescriptions to be digitally despatched to Parata methods, which may then robotically put together prescriptions in vials, bottles, pouches or blister packages for almost all pharmacy finish markets from retail to hospitals to long-term care to mail order and digital pharmacies, BD executives stated.

“Parata expands BD’s options to a brand new space of the high-growth pharmacy automation house and is a major instance of BD executing our disciplined M&A technique,” BD chairman, chief govt and president Tom Polen stated. “Parata has a extremely enticing monetary profile and compelling worth proposition that meets all of our rigorous funding standards on progress, profitability and returns. With the addition of Parata, BD additional advances our 2025 progress technique round sensible, related care and enabling new care settings.”